Skip to main content
Fig. 7 | Breast Cancer Research

Fig. 7

From: Nitric oxide deficiency and endothelial–mesenchymal transition of pulmonary endothelium in the progression of 4T1 metastatic breast cancer in mice

Fig. 7

Platelet basal activity and ADP-induced reactivity in orthotopic murine 4T1 breast cancer model. Platelet basal activation and their ADP-induced reactivity assessed as percentage of platelet surface expression of P-selectin (a), active form of receptor GPIIb/IIIa (b), von Willebrand factor (vWF) binding (c), and fibrinogen binding (d) (see Methods), presented as median and IQR. Black circle indicates outlier. Data analyzed with Kruskal–Wallis test followed by Dunn’s multiple comparison test since they either did not display normal distribution and/or their variances were heterogeneous. a n = 10, n = 7, n = 9, n = 7, n = 8, and n = 12 for healthy control, 1st, 2nd, 3rd, 4th, and 5th week, respectively; and n = 9, n = 7, n = 8, n = 6, n = 6, and n = 12 for healthy control, 1st, 2nd, 3rd, 4th, and 5th week after ADP stimulation. b n = 10, n = 7, n = 9, n = 7, n = 8, and n = 13 for healthy control, 1st, 2nd, 3rd, 4th, and 5th week, respectively; and n = 10, n = 7, n = 9, n = 7, n = 7, and n = 13 for healthy control, 1st, 2nd, 3rd, 4th, and 5th week after ADP stimulation. c n = 10, n = 7, n = 8, n = 7, n = 8, and n = 18 for healthy control, 1st, 2nd, 3rd, 4th, and 5th week, respectively; and n = 10, n = 7, n = 9, n = 7, n = 7, and n = 19 for healthy control, 1st, 2nd, 3rd, 4th, and 5th week after ADP stimulation. d n = 10, n = 7, n = 8, n = 7, n = 8, and n = 20 for healthy control, 1st, 2nd, 3rd, 4th, and 5th week, respectively; and n = 9, n = 7, n = 9, n = 7, n = 8, and n = 20 for healthy control, 1st, 2nd, 3rd, 4th, and 5th week after ADP stimulation. Statistical significance at level of *P < 0.05, **P < 0.01, and ***P < 0.001

Back to article page